Navigation Links
Advanced Life Sciences Announces Restanza(TM) Shows Efficacy Against Malaria
Date:5/26/2010

portfolio of indications that we can develop and commercialize either on our own or in partnership with pharmaceutical companies with established anti-infective franchises."

About Malaria

Malaria is a parasitic disease that is characterized by high fevers, shaking chills, flu-like symptoms, and anemia, and requires hospitalization. Malaria is typically caused by a parasite that is transmitted from one human to another by the bite of infected mosquitoes. Malaria can also be transmitted from a mother to her unborn baby and by blood transfusions. In humans, the parasites (sporozoites) travel to the liver where they mature and release another form, the merosoites, which enter the bloodstream and infect red blood cells. The parasites multiply inside the red blood cells, which then rupture within 48 to 72 hours, infecting more red blood cells. The first symptoms usually occur 10 days to four weeks after infection, though they can appear as early as eight days or as long as a year after infection.

Malaria is a serious health problem in much of the tropics and subtropics and represents a major disease hazard for travelers to these regions and other warm climates. The widespread prevalence of malaria in Africa poses a severe social and economic threat. The Centers for Disease Control and Prevention (CDC) estimates that there are 300-500 million cases of malaria each year, resulting in more than one million deaths, many among very young children. Conventional treatment includes chloroquine, quinidine or quinine. In some areas of the world, the parasites have developed resistance to antibiotic treatments (doxycycline, tetracycline or clindamycin, atovaquone plus proguanil, mefloquine or artesunate, or the combination of pyrimethamine and sulfaxcozine). This has led to difficulty in controlling both the rate of infection and spread of this dis
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Tumor-Targeted Rexin-G Prolongs Survival in Gemcitabine-Resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies (ASCO 2010)
2. Elekta / Mitsubishi Electric Collaboration Helps Japans Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
3. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-111 and Herceptin in Patients with Advanced Her2 Positive Breast Cancer
4. Advanced BioFuels Association Applauds U.S. Sen. Bill Nelsons Leadership as Biofuels Tax Incentives Bill Is Introduced
5. Advanced Life Sciences to Host 2010 First Quarter Financial Results Conference Call and Webcast
6. Upgrade to Advanced Photon Source Announced by DOE
7. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
8. Atherotechs Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
9. Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs
10. Advanced Instruments Signs License and Sensor Development Agreement With Cantimer, Inc.
11. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , A major pan-European survey ... delivery of care has revealed changing trends in many ... the provision of healthcare services across the continent. The ... European Gastroenterology (UEG), have been announced today and led ... the burden of GI disorders across Europe ...
(Date:10/20/2014)... Virginia (PRWEB) October 20, 2014 ... NDA Partners LLC, announced today that Ellen Teplitzky, ... legal support for the pharmaceutical industry, has joined ... manager of its legal services practice. NDA ... and expert witness and testimony, to top law ...
(Date:10/19/2014)... , Oct. 19, 2014 NextCODE Health, which ... whole genome in real time, today announced the launch of ... NextCODE Exchange , at the American Society of Human Genetics ... To learn more, sign up and apply for free beta ... unique features and benefits can be viewed here . ...
(Date:10/19/2014)... October 19, 2014 The report "Chocolate, ... Share, Trade, Prices, Geography Trend and Forecast (2011 - ... category, and geography and studies the major market drivers, ... America, Europe, and Asia. , The global chocolate market ... $98.3 billion in 2016 at an estimated CAGR of ...
Breaking Biology Technology:Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... 2012 AMRI (NASDAQ: AMRI ) announced ... functions. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ... teams are being combined into one functional sales organization, ... promoted to Vice President, Business Development, North America. This ...
... 23, 2012   Covington & Burling represented AstraZeneca in ... the agreement, AstraZeneca will pay $32 per share ... (Logo: http://photos.prnewswire.com/prnh/20120423/CL92331LOGO  ) ... business with a primary focus on the discovery, ...
... Ahram Biosystems, Inc., a leading innovator of new life ... the economy model of its innovative portable PCR system. The ... PCR amplification with high speed and sensitivity in a fully ... provides three " Standard Fast" speed levels delivering 30-cycle ...
Cached Biology Technology:AMRI Strengthens Business Development and Marketing Groups 2AMRI Strengthens Business Development and Marketing Groups 3Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences 2Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series 2
(Date:10/15/2014)... ability to assess the pandemic risk from strains of ... must not allow ourselves to become complacent that the ... consortium of scientists. , Influenza pandemics arise when a ... to develop widespread immunity – spreads in the human ... past 100 years, the worst of which – the ...
(Date:10/15/2014)... 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market releases photos and video of ... on Monday October 13 th . Gino ... and angel investor Mr. Chad A. Verdi rang ... NXT-ID thanked his investors and employees "for their work and dedication ...
(Date:10/14/2014)... Ohio (Oct. 14, 2014)—It,s been millions of years since ... a team led by Ohio University scientists is breathing ... model airflow through dinosaur snouts. The research has important ... only breathe but to enhance the sense of smell ... ,nosy, animals," said Ohio University doctoral student Jason Bourke, ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... The American Association for Cancer Research, the world,s oldest ... M.D., on his nomination by President Barack Obama to ... Institute (NCI). "Dr. Varmus will bring to the ... as the foundation for understanding healthy function as well ...
... the venue for the 3rd Baltic Congress of Osteoporosis ... congress, to be held in English, is jointly organized ... Lithuanian Osteoporosis Foundation, Lithuanian Association of Metabolic Bone Diseases ... the most disabling conditions of older adults and elderly. ...
... international team of scientists have discovered that climate change played ... the late quaternary era, 50,000 years ago. Their study, published ... hotly debated topic by using global data modelling to build ... present (BP) 65% of mammal species weighing over 44kg went ...
Cached Biology News:AACR nomination of Harold E. Varmus, M.D., as director of the NCI 2New study reveals link between 'climate footprints' and mass mammal 2
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Immunofixation Gel Kit, requires IF100 Reactivity: Human Applications: Immunofixation ...
...
...
Biology Products: